Today we’d like to introduce you to Dr Lopamudra Das Roy.
Hi Dr Lopamudra, we’re thrilled to have a chance to learn your story today. So, before we get into specifics, maybe you can briefly walk us through how you got to where you are today?
Dr. Lopamudra Das Roy, Founder and President of Breast Cancer Hub (BCH) established in 2017 in NC, traces her life’s mission to a moment that marked her forever.
At the age of 12, Dr. Das Roy attended the funeral of a close friend’s mother. When she innocently asked about the cause of death, she was met with silence. People hesitated, whispered, and hushed her when she repeated the words “Breast Cancer.” She remembers feeling shocked and deeply disturbed – “Is this the respect we give to a mother who lost her life, that we cannot even name the disease that took her away?” That moment planted a lasting pain within her, and a powerful question: why was cancer treated as a taboo rather than a disease to be confronted?
As she grew older, she realized that cancer had become a household name and, tragically, a death sentence-not because it was always incurable, but because it was detected too late. This realization drove her to pursue cancer research, to understand the etiology of the disease, uncover its signaling pathways, and contribute to effective treatments-while also educating society about early detection and prevention to reduce cancer mortality worldwide.
Born into a family of physicians and healthcare providers, service was deeply ingrained in her upbringing. Her grandfather, Late Dr. K. N. Das, and her father, Late Dr. Chandra Sekhar Das, served communities across Assam and Northeast India, while her mother, Rita Das, dedicated her life to selfless humanitarian service. Inspired by their legacy, Dr. Das Roy followed the same path-with a singular passion for cancer research and community service.
Her dream of building Breast Cancer Hub was further shaped by conversations with breast cancer patients and advocates in the United States, where even in the most advanced healthcare systems, cancers were missed due to dense breast tissue and limitations of mammography. Her heart sank as she witnessed young mothers losing their lives to late detection-an issue far more severe in developing countries.
Through extensive travel and grassroots work in developing regions, Dr. Das Roy observed alarming gaps in breast health awareness. Regardless of education or socioeconomic status, breast cancer mortality remains disproportionately highespecially in rural areas. The stigma surrounding the word “breast,” combined with shyness and ignorance, prevents open discussion, routine screening, and early medical attention. Knowledge of breast self-examination, clinical exams, mammograms, and ultrasounds is limited, leading women to seek care only when tumors are advanced and metastatic. She also highlights the rising incidence of breast cancer in men, who often suffer in silence due to stigma and embarrassment associated with what is perceived as a “women’s disease.”
In 2017, after more than two decades as a distinguished cancer scientist, principal investigator, and research professor, Dr. Das Roy made a life-altering decision. She resigned from her academic career to dedicate herself full time, pro bono, to founding and growing Breast Cancer Hub-providing 100% free services with a mission to bridge the gap between developed and developing countries, break the breast and cancer taboo, penetrate underserved communities, and save lives through early detection, care, and sustainable cancer management.
Today, BCH works across the U.S., Asia, Africa, and beyond through its community-driven grassroots sustainable model, guided by the belief:
“Coming together to fight ALL cancers for families and communities faced with cancer.”
Because at BCH, when we save a life, we save a family.
I’m sure it wasn’t obstacle-free, but would you say the journey has been fairly smooth so far?
The challenges have been deeply personal. Dr. Lopamudra Das Roy has made extraordinary sacrifices, often placing the mission above her safety. She left her young children behind to travel alone to remote, underserved regions of India, Sierra Leone, Nigeria, working in harsh environments with limited infrastructure and scarce medical resources. As a woman, she faced real personal safety risks, cultural barriers, and even contracted serious illnesses, yet she persisted, working relentlessly to guide patients toward diagnosis, treatment, and compassionate care.
Leading Breast Cancer Hub as a global humanitarian initiative while personally mentoring volunteers, supporting patients through complex healthcare systems, responding to crises such as COVID-19 and natural disasters, and maintaining scientific rigor has been emotionally and physically demanding. The weight of responsibility knowing that delays or missed opportunities could cost lives has been immense since she serves the underprivileged who have no one to take care of them.
Yet every challenge has strengthened BCH’s resolve. The organization’s growth has been powered not by ease, but by belief-by volunteers, patient, survivors, caregivers, students, physicians, and donors who stand together in service. These struggles have shaped BCH into a model rooted in ethics, integrity, transparency, and compassion.
The road has been hard, but it has been purposeful. And every life saved, every cancer detected early, and every family supported reaffirms why the journey continues.
Thanks – so what else should our readers know about your work and what you’re currently focused on?
Dr. Lopamudra Das Roy is a Distinguished Cancer Scientist, Research Professor, and Principal Investigator, and the Founder and President of Breast Cancer Hub (BCH). In 2017, she resigned from a successful academic and research career to dedicate herself full time to pro bono humanitarian service-creating and growing BCH to deliver 100% free cancer services. Her mission is to save lives by driving impactful, sustainable change at the grassroots level and bridging healthcare gaps between developed and developing countries.
Breast Cancer Hub primarily serves North Carolina and communities across the United States, India, Africa, and globally through a hybrid outreach model.
Dr. Das Roy brings more than 24 years of experience in cancer research, genetics, teaching, and mentoring undergraduate and Ph.D. candidates. She served as a Research Professor at the University of North Carolina at Charlotte, where she was awarded multiple grants as Principal Investigator from the U.S. Department of Defense Cancer Research Program, focusing on targeted therapies and signaling pathways in metastatic breast and pancreatic cancer. She also served as Research Director at OncoTAb Inc, specializing in cancer diagnostics and therapeutics, where she received grant from the National Cancer Institute as Principal Investigator. Earlier in her career, she served as a Lecturer of Genetics at Garden City University in Bengaluru, India.
Her pioneering scientific work has resulted in numerous high-impact publications, inventions, citations, and global media coverage. She gained international recognition for her breakthrough discovery linking breast cancer metastasis with arthritis-related signaling pathways, acknowledged by worldwide press release by the American Association for Cancer Research in 2012. Her transformative grassroots cancer research with BCH-spanning breast, cervical, oral, and other cancers-has been featured at the American Society of Clinical Oncology (ASCO) and highlighted at the San Antonio Breast Cancer Symposium, the world’s largest breast cancer conference, where it received a prestigious Spotlight Award.
Dr. Das Roy is a sought-after keynote speaker at international conferences and serve as a scientific reviewer for Department of Defense grants and peer-reviewed cancer journals. She also serves as an Honorary Advisory Board Member of Healthy Cabarrus (Cabarrus Health Alliance, NC) and as an External Volunteer Member of the Institutional Biosafety Committee at the University of North Carolina at Charlotte.
She earned her Ph.D. in Cancer Molecular Biology (Genetics) from Assam University, India, with additional research training in Biochemistry at Delhi University. She completed her postdoctoral fellowship at the Mayo Clinic College of Medicine, specializing in cancer immunology and therapeutics, and holds an MBA from Northwestern University Kellogg School of Management.
Breast Cancer Hub and Dr. Das Roy have received numerous honors, including Best Community Impact Organization of the Year 2025 from the Carolinas Asian-American Chamber of Commerce. Dr. Das Roy is a 2025 KNOW 100 Women in America Awardee, 2025 NC 50 Women to Know, and recipient of the NRI Achievers Award 2025 – Global Health Humanitarian of the Year, recognizing her leadership in community oncology, health equity, and public health.
Additional accolades include 100 Global Women in Leadership, The Charlotte Ledger 40 Over 40 Award, George H. W. Bush Points of Light Award, USA President’s Lifetime Achievement Award, Falling Walls Science Breakthroughs Finalist, and recognition as one of the 50 Most Influential Women by The Mecklenburg Times. Her work and journey have been widely featured in national and international media, podcasts, and publications.
Dr. Das Roy is best known for creating a unique, science-driven grassroots model that seamlessly integrates rigorous cancer research with compassionate, end-to-end community care. BCH delivers 100% free services, including cancer education, door-to-door early detection screening, patient report analysis, one-on-one medical guidance, treatment navigation, village adoption programs, patient support groups, treatment aid, food support, and student mentorship-creating the next generation of “torch bearers.” BCH serves women, men, and LGBTQ+ populations while addressing all types of cancer through a holistic, community-centered, personalized patient approach. Nearly 80% of Dr Das Roy’s work is carried out anonymously to respect patient privacy, as she guides countless patients every day with her expertise. Any website or social media presence is used only when donor support is involved or to acknowledge collaborators and volunteers contributing to the mission. Every donation is directed entirely to mission programs, making BCH a fully volunteer-driven, trust-based organization.
Dr. Das Roy considers her greatest reward not awards or recognition, but the joy of bringing hope and healing to families whose cancers were detected early-lives that may otherwise have gone unnoticed and untreated.
Where do you see things going in the next 5-10 years?
Over the next 5-10 years, cancer care will shift decisively from late-stage treatment to early detection, prevention, and precision care. Advances such as AI-assisted imaging, risk-based screening, liquid biopsies, and personalized therapies will improve early diagnosis-especially for populations historically missed by standard screening models.
Another major change will be the growing integration of community oncology and public health. Addressing stigma, access, navigation, and social determinants of health will be recognized as essential to improving outcomes, not optional. Technology-telemedicine, digital navigation, and hybrid care models-will expand reach, particularly for rural and underserved communities
.
Most importantly, the industry will be driven by health equity, accountability, and collaboration. The future of cancer care is not just better treatments-but earlier detection, equitable access, and saving lives before cancer becomes a crisis.
Contact Info:
- Website: https://www.breastcancerhub.org/
- Instagram: https://www.instagram.com/breastcancerhub/
- Facebook: https://www.facebook.com/breastcancerhub/
- LinkedIn: https://www.linkedin.com/company/breastcancerhub/
- Twitter: https://x.com/breastcancerhub
- Youtube: https://www.youtube.com/channel/UCZvTfrE-8pYTKGVPlllC0Yg/videos
